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ABSTRACT
The aim of this current randomised controlled trial was to evaluate the effects of a home-based physical
activity (PA) intervention on cardiorespiratory fitness in breast cancer survivors�. Thirty-two post-adju-
vant therapy breast cancer survivors (age = 52 ± 10 years; BMI = 27.2 ± 4.4 kg∙m2) were randomised to a
10 six-month home-based PA intervention with face-to-face and telephone PA counselling or usual care.
Cardiorespiratory fitness and self-reported PA were assessed at baseline and at six-months. Participants
had a mean relative _VO2max of 25.3 ± 4.7 ml∙kg
−1∙min−1, which is categorised as “poor” according to
age and gender matched normative values. Magnitude-based inference analyses revealed likely at least
small beneficial effects (effect sizes ≥.20) on absolute and relative _VO2 max (d = .44 and .40, respec-
15 tively), and total and moderate PA (d = .73 and .59, respectively) in the intervention compared to the
usual care group. We found no likely beneficial improvements in any other outcome�. Our home-based
PA intervention led to likely beneficial, albeit modest, increases in cardiorespiratory fitness and self-
reported PA in breast cancer survivors. This intervention has the potential for widespread implementa-
tion and adoption, which could considerably impact on post-treatment recovery in this population.
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Globally, breast cancer is the leading cause of cancer death and
the most frequently diagnosed cancer among females (Ferlay
25 et al., 2014). From 2008 to 2012, the number of women living
with a diagnosis of breast cancer across the world increased from
5.2 to 6.2 million (Bray, Ren, Masuyer, & Ferlay, 2012; Ferlay et al.,
2014). Due to an increase in the number of women surviving
breast cancer, owing largely to early detection and improved
30 treatment strategies, we are now beginning to see the long-term
consequences of a cancer diagnosis and treatment. One such
long-term effect appears to be an excess of cardiovascular mor-
tality in breast cancer survivors (Eloranta et al., 2012), particularly
in those over the age of 65 (Patnaik, Byers, DiGuiseppi, Dabelea, &
35 Denberg, 2011). The precise reason for this increased risk of
cardiovascular disease (CVD) is unknown. However, it is possible
that prolonged exposure to aggressive adjuvant therapies, such
as surgery, radiation therapy, and chemotherapy, can cause
injury to components of the cardiovascular system. These cardi-
40 ovascular insults coupled with unfavourable lifestyle changes,
such as weight gain and reduced physical activity (PA), can lead
to an increased susceptibility to further cardiovascular damage
and risk of premature CVD mortality (Hoff et al., 1979AQ6 �; Jones,
Haykowsky, Swartz, Douglas, & Mackey, 2007; Shan, Lincoff, &
45 Young, 1996). This phenomenon has been termed the “multiple-
hit” hypothesis (Jones et al., 2007).
A combination of disease pathology, treatment regimens,
weight gain, and low PA can�compromise cardiorespiratory
fitness of breast cancer survivors (Jones et al., 2007).
50 Cardiorespiratory fitness, as measured by maximal oxygen
uptake ( _VO2max), reflects the highest rate at which oxygen is
transported and utilised by the body during maximal exercise
(Bassett & Howley, 2000). Breast cancer survivors have been
reported as having _VO2max values 22–25% lower compared to
55their age matched healthy, sedentary non-cancer peers (Jones
et al., 2012; Peel, Thomas, Dittus, Jones, & Lakoski, 2014). AQ7�In a
recent review it was reported that post-adjuvant therapy
breast cancer patients had a weighted mean _VO2 max of
22 ml∙kg−1∙min−1, a value 10% lower than that observed in
60pre-adjuvant therapy patients (Peel et al., 2014).�Worringly,
��low cardiorespiratory fitness has been found to inversely
associate with breast cancer-related deaths, cardiovascular
and all-cause mortality (Blair, 1996; Peel et al., 2009). Peel
and colleagues (2009) found that low cardiorespiratory fitness
65of below eight maximal metabolic equivalents (MET) (approx-
imates a _VO2max of 28ml∙kg
−1∙min−1) was associated with a
nearly three-fold increase in breast cancer deaths compared to
those who reached 10 MET (~35 ml∙kg−1∙min−1) or greater.
Encouragingly, increased PA�associate�s with reduced CVD
70mortality in adults (Sattelmair et al., 2011), and improved
CVD risk profile (Knobf & Coviello, 2012; Thompson, Visich,
Singleton, & Saltarelli, 2003), fewer recurrences, and lower
breast cancer-related mortality in women with breast cancer
(Ibrahim & Al-Homaidh, 2011; Lahart, Metsios, Nevill, &
75Carmichael, 2015). Previous meta-analyses have found sig-
nificant improvements in the cardiorespiratory fitness of
breast cancer populations (during and after adjuvant ther-
apy) participating in PA interventions within randomised
controlled trials (Fong et al., 2012; Furmaniak, Menig, &
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80 Markes, 2016; Speck, Courneya, Mâsse, Duval, & Schmitz,
2010). However, PA interventions involving breast cancer
populations typically involve supervised, facility-based exer-
cise programmes, which can be costly to run, time-consum-
ing, and require access to specialist facilities. Therefore,
85 given that health care resources are finite, more pragmatic
interventions that can overcome some of the barriers stated
above and improve the health of patients are more desirable
to those making clinical, managerial and policy decisions.
Home-based PA interventions can potentially mitigate
90 many of the barriers to PA, such as transportation and
scheduling difficulties, cost, and need for facilities (Pinto,
Frierson, Rabin, Trunzo, & Marcus, 2005). However, there are
a limited number of randomised controlled trials that have
investigated the effects of home-based PA interventions on
95 cardiorespiratory fitness in breast cancer survivors (Fillion
et al., 2008; Irwin et al., 2014; Pinto et al., 2005; Rogers
et al., 2009). Only one of these previous studies (Irwin
et al., 2014) assessed cardiorespiratory fitness using the
gold standard method (i.e., _VO2max measured via indirect
100 calorimetry). The other previous studies used walking tests to
assess cardiorespiratory fitness. Walking test outcome is
dependent on a combination of movement efficiency,
motor skills, and cardiorespiratory fitness, and therefore, a
change in walking distance may not be fully representative
105 of a change in _VO2max (Ekelund, 2008). Additionally, all
previous home-based PA interventions that employed walk
tests (Fillion et al., 2008; Pinto et al., 2005; Rogers et al.,
2009) used change in single walk distance to represent
changes in cardiorespiratory fitness, which has been found
110 to vary up to 33% more than a change in best-of-two walk
distance (Chandra et al., 2012). Accordingly, a more precise
measure of _VO2max may be needed to elucidate actual
changes in _VO2max. Therefore, the aim of this current
study was to investigate the effects of a home-based PA
115 intervention on the cardiorespiratory fitness ( _VO2max mea-
sured via indirect calorimetry) of breast cancer survivors.
Methods
Trial design
The current study is a two-armed, parallel design randomised
120 controlled trial that compares a six month home-based PA
intervention to usual care in post-adjuvant breast cancer sur-
vivors that represents a substudy within a larger parent trial
(Lahart, Metsios, Nevill, Kitas, & Carmichael, 2016)
(NCT02408107). The present study includes additional out-
125 comes not included in the parent publication, including a
direct measure of cardiorespiratory fitness, and cardiovascular
outcomes (heart rate peak and resting heart rate, systolic and
diastolic blood pressure, and mean arterial pressure). All mea-
surements were recorded at baseline before randomization
130 and after the six-month intervention. The study was approved
by the Black Country NHS Ethics Committee. All participants
provided written consent prior to data collection.
Participants
Forty per cent (n = 32/80) of the patients randomised to
135intervention and usual care groups in the parent study were
also randomised to the substudy. Women attending breast
cancer clinics at Russells Hall Hospital (The Dudley Group
NHS Foundation Trust, UK), were invited to enrol in the
study by the breast team, which included consultant and
140specialist nurses, between January 2010 and March 2013.
Interested patients were given a study information booklet
and were contacted by the primary researcher via telephone
a week later. Participants were eligible to participate if they
were: 1) females aged 18–72 years, 2) diagnosed with invasive
145breast cancer (Stage I-III) within two years of enrolment, 3)
post-surgery and had no surgery planned for the next six
months at least, 4) had fully completed adjuvant therapy
(radiotherapy and/or chemotherapy) not including hormonal
therapy, 5) no previous malignancy, 6) consent to be rando-
150mised 7) and willing to maintain contact with the investigators
over the six months. Exclusion criteria included: 1) inability to
participate in PA because of severe disability (e.g., severe
arthritic conditions), 2) psychiatric illness and 3) vulnerable
subjects, such as pregnant women or any other patient
155where PA was not approved by their oncologist due to the
presence of one or more contraindications to exercise in
cancer patients (American College of Sports Medicine
[ACSM], 2013). Participants who self-defined as physically
active at the time of enrolment were not excluded from
160participation.
Home-based PA intervention
Following consent and randomisation, breast cancer patients
in the intervention group received an intervention aimed at
encouraging the adoption of a more physically active lifestyle.
165Participants received a 30–45 min face-to-face consultation,
followed by a support telephone call at the end of months
one, two and three. During each of the last two months (4 and
5) patients received a mailed PA reminder leaflet encouraging
their participation in home-based PA. The face-to-face consul-
170tation was based on the four core motivational interviewing
principles: expressing empathy, developing discrepancy, roll-
ing with resistance, and supporting self-efficacy (Miller &
Rollnick, 2013; Rosengren, 2009). To ensure consistency in
intervention delivery across sessions and participants, a semi-
175structured motivational interviewing-based intervention pro-
tocol was developed to guide intervention delivery. The topics
covered in the 30–45 min consultation were similar to other
trials (Baruth, Wilcox, Der Ananian, & Heiney, 2015; Matthews
et al., 2007; Pinto et al., 2005; Rogers et al., 2009) that incor-
180porated a PA counselling component, including: current PA
behaviour, decision balance exercise; benefits of PA in general
and specific to breast cancer survivors; perceived barriers;
prompts to seek social support, goal setting, types and inten-
sities of PA (e.g., explanation of light, moderate and vigorous
185PA with examples specific to participants, such as taking a
brisk walk so that you are mildly breathless but can still hold a
conversation); safety advice. We also provided basic lifestyle
2 I. M. LAHART ET AL.
information such as basic dietary information, portion size, fat
intake, smoking, and hydration in generally and during PA.
190 The initial goal of the intervention (months 1–3) was for
participants to progress towards accumulating 30 minutes of
moderate-intensity PA on three to five days per week.
Participants were allowed to choose the mode of PA they per-
formed during the intervention, with walking and aerobic exer-
195 cise strongly recommended by the researchers. During months 3
to 6, the intervention participants were encouraged to work
towards accumulating at least 30 minutes of moderate-intensity
PA on five to seven days per week in broad agreement with
current public health guidelines (Bull & Expert Working Groups,
200 2010). If participants were already achieving this on trial entry
they were, as a minimum, actively encouraged to maintain their
level of PA. The focus of the follow-up phone calls (end of
months 1–3) was to prevent relapse back to inactivity and/or
improve maintenance of PA (accumulate 30 min of moderate-
205 intensity PA on 3–5 days/week), covering topics similar to the
face-to-face consultation. Calls lasted approximately 15–20 min
andwere guided by a standardised phone call script. Participants
were encouraged to telephone the research team should they
encounter any problems or relapse in their efforts to increase
210 their PA. Therefore, our intervention represented a pragmatic
step down approach (i.e., from in-person sessions to telephone
calls to postcard prompts), that could feasibly be employed by
cancer-care nurses in routine clinical practice. Participants were
also given a PA pack consisting of an information booklet and a
215 DVD (previously developed by Breast Cancer Care) that provided
further information of topics such as exercising safety, exercise
intensity, dealing with fatigue and exercising with lymphedema.
Information about local physical activity opportunities was also
provided, including an exercise initiative run in local parks.
220 During the intervention period, participants were encouraged,
but not required to keep PA diaries to check whether they were
achieving 150 min of moderate-vigorous PA over each week.
Participants were advised to refrain from activity if they experi-
enced any problems relating to the PA intervention (e.g., chest
225 pain or developed a joint problem). If these circumstances
occurred, patients would have been advised to contact the
clinical team, and the clinician of the research team would have
made a clinical decision based on the contraindications and
precautions to PA for patients with cancer as to whether the
230 patient refrained from PA temporarily or withdrew from the
intervention (ACSM, 2013).
Usual care group
Since not informing patients about the benefits of PA may be
considered unethical, participants randomised to the usual
235 care arm were told standard information regarding PA (i.e.,
the current recommended PA guidelines), as provided to all
breast cancer patients treated at the site. The usual care group
did not receive guidance on how to meet the recommended
PA guidelines. Participants completed the same baseline and
240 post-six month intervention assessments as the PA interven-
tion group. After completion of the intervention, participants
in the usual care group were encouraged to adopt a more
physically active lifestyle and were given the same guidance
and physical activity pack as the intervention group.
245Study outcomes
The primary outcome of the current substudy was cardiore-
spiratory fitness ( _VO2max). Secondary outcomes included
exercise tolerance test variables, time to exhaustion (TTE)
and peak heart rate (HR peak); resting cardiovascular mea-
250sures, resting HR (RHR), systolic and diastolic blood pressure
(BP), and mean arterial pressure (MAP); self-reported physical
activity outcomes via International PA Questionnaire (IPAQ,
included total, walking, moderate, and vigorous PA in MET-
min∙wk−1; and anthropometric (body mass and BMI) measures.
255All assessments were made at baseline and within two weeks
of completing the six-month intervention. All participants
were subjected to the same data collection procedures over-
seen by investigators (exercise physiologists) who were not
blinded to group allocation.
260Exercise tolerance and cardiovascular outcomes
Exercise tolerance tests were performed on a treadmill (H/P/
Cosmos, Pulsar, Nussdorf-Traunstein, Germany) using the vali-
dated Bruce test protocol (Bruce, Blackmon, Jones, & Strait,
1963). The Bruce test was started at 2.74 km∙h−1 (1.7 m∙h−1) and
265at incline of 10% for three minutes. At three minute intervals the
incline of treadmill increased by 2% and speed increase to 4.02,
5.47, 6.76, 8.05, 8.85, 9.65, 10.46, 11.26 and 12.07 km∙h−1 in each
stage (10 stages in total), respectively. Ventilatory gas exchange
was determined using a calibrated breath-by-breath system
270(Metalyzer 3B, Cortex Biophysik GmbH, Leipzig, Germany) allowing
continuous measurement of gas variables, including _VO2, _VCO2,
minute ventilation, and respiratory exchange ratio (RER).
Moreover, during the test heart rate was also monitored using a
heart rate monitor and strap (Polar USA, Woodbury, NY). Testing
275was terminated when the participant reached voluntary exhaus-
tion. The test was also discontinued if the participants showed
signs of sudden paleness, rapid change in HR, dizziness or cold
sweat (none of the participants experienced any of these symp-
toms). _VO2max was determined by taking the highest _VO2 value
280averaged over a 20-s period during the test. To determinewhether
a maximal effort was achieved the following secondary criteria
were used: _VO2 plateau (change in _VO2 ≤ 50 ml/min), RER ≥1.10
and�HR�peak within 10 bpmof the age-predictedmaximum (220 –
age) (Astorino, Robergs, Ghiasvand, Marks, & Burns, 2000).
285Prior to performing the exercise tolerance test, RHR and BP
was assessed three times on the brachial artery using a
Datascope Accutorr Plus (Datascope, Montvale, NJ, USA),
while the participant was resting in a seated position.
Patients were given five minutes of sitting at rest before the
290first BP measurement was taken. Both the exercise tolerance
and BP assessments were conducted in controlled conditions
in the cardiovascular laboratory of the Research and
Development Unit of the hospital on a separate day to the
other outcome measurements.
295Physical activity and anthropometric outcomes
Participants completed the validated IPAQ-long form question-
naire, which assesses the duration (number of days x min per
day) that an individual has engaged in walking, moderate, and
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vigorous PA across four domains (occupational, active transpor-
300 tation, domestic, and leisure) over the past seven days (Craig
et al., 2003). PA data were then used to calculate the�MET�-based
IPAQ score by weighting each type of activity by its MET energy
requirement (3.3 x walking duration; 4 xmoderate PA duration; 8
x vigorous PA duration). Data were summed across activity
305 domains to produce a weighted estimate of total PA (primary
outcome) from all reported activities per week (MET-min∙wk−1),
as well as a subtotal of activity for each of the four domains, as
well as walking, moderate and vigorous PA. The IPAQ has good
reliability (Spearman’s rho = .8) andmoderate concurrent validity
310 (Spearman’s rho = .33) when compared to accelerometer data
(Spearman’s rho = .33) (Craig et al., 2003).
Body mass was also measured via the Tanita BC-418 MA
Analyser (Tanita Corporation, Tokyo, Japan), and was recorded
to the nearest .1 kg. Standing height was measured without
315 shoes to the nearest .5 cm on a portable stadiometer (Seca
214 Road Rod, Seca gmbh & co. kg., Hamburg, Germany). BMI
(kg∙m2) was calculated on the basis of measured height and
mass (mass in kg multiplied by height in m squared).
Sample size calculation and randomisation
320 Power calculations for the parent study, based on total PA as
the primary outcome, estimated that at least 36 participants in
each group (N = 72) would be required, using a between-
group mean (s) change in self-reported PA of 16.5 (25.1) MET-
h∙wk−1 found in a similar trial (Matthews et al., 2007). Sample
325 sizes were estimated with a spreadsheet developed by
Hopkins (2006)AQ8 �using data extracted from a recent similar
study (Courneya et al., 2003). This method requires sample
sizes approximately one-third or lower than those of tradi-
tional methods. Assuming a change in _VO2max of 3.4 ml/kg/
330 min with a within-subject SD of 1.55 ml/kg/min, we needed a
total of 6 participants. Using a traditional method of sample
size calculation (5% alpha and 20% beta), we needed a total of
15 participants (i.e., 8 per group) to detect a 3.4 ml/kg/min
change in _VO2max (within-subject SD of 1.55 ml/kg/min). Due
335 to available resources, we randomised 40% of the parent
sample (32 participants, 16 in each group) to our substudy
sample. At a Clinic Trials Unit on a different site, a computer
generated random numbers list was used to allocate all parti-
cipants into intervention or usual care groups (concealed from
340 the primary researcher), and the same sequence was used to
allocate 40% (n = 32/80) of participants in each group into the
current substudy. Patients were allocated to intervention and
usual care groups on a 1:1 allocation ratio and were stratified
based on adjuvant chemotherapy.
345 Statistical analysis
We investigated pre-post-intervention differences between the
intervention and usual care groups using a contemporary magni-
tude-based inferences approach (Batterham & Hopkins, 2006). In
this approach, mean effects of the PA intervention and their 90%
350 confidence limits were estimated with a spreadsheet (Hopkins,
2006AQ9 �) via the unequal-variances t statistic computed for change
scores between baseline and post-intervention in the two groups
and adjusted for baseline values of each outcome. Each partici-
pant’s change score was expressed as a percentage of baseline
355score via analysis of log-transformed values, to reduce bias arising
from non-uniformity of error. For this approach, effect sizes were
calculated by dividing the log-transformed mean differences
between intervention and usual care groups divided by the
pooled log-transformed baseline s of outcomes. The
360spreadsheet also computed quantitative and qualitative chances
that the true effects were beneficial, trivial, and harmful when a
value for the smallest meaningful change was entered. A Cohen
unit of .2 was employed as the smallest meaningful change in
outcomes (Cohen, 1988). Where the chance of benefit and harm
365are both >5%, the effect is deemed unclear. Qualitative descriptors
were then assigned to the quantitative percentile scores as fol-
lows: 25–75% possible, 75–95% likely, and >99%most likely. Effect
sizes of <.20 were interpreted as trivial, .2 to.59 as small, .6 to 1.19
as moderate, and ≥1.2 as large (Hopkins, Marshall, Batterham, &
370Hanin, 2009).33 To further enhance the practical application of the
findings, we calculated Cohen’s U3 index, an index used to deter-
mine the percentile gain in an intervention group (Durlak, 2009).34
For example, a Cohen’s d of .50 suggests that, on average, a
participant in the intervention group would be at approximately
375the 69th percentile in terms of improving a particular outcome
measure (or is 19%higher than average control group participant).
As recommended for small samples, we used the Process
macro for SPSS to perform nonparametric bootstrapping ana-
lyses (Hayes, 2013; Preacher, Rucker, & Hayes, 2007) to test the
380mediational model of body mass (kg) as a mediator of the
relationship between group allocation (PA intervention or
usual care) and relative _VO2max (ml∙kg
−1∙min−1). In these ana-
lyses, mediation is significant if the 95% Bias Corrected and
accelerated confidence intervals (BCa 95% CI) for the indirect
385effect do not include zero (Preacher et al., 2007).
Results
Flow of participants through the trial and recruitment
Forty participants each were randomised to the intervention
and usual care groups of the parent study and of the forty
390participants in each group 40% (16 in each group) were
randomly allocated to the cardiorespiratory fitness substudy
presented here. Twenty nine of the substudy participants
completed the trial, with 15 and 14 completers in the inter-
vention group and usual care group, respectively. One parti-
395cipant discontinued the intervention due to breast cancer
recurrence and two participants dropped out of the usual
care group due to not wanting to come back to the hospital
for post-intervention testing. Flow of participants through the
study is provided in Figure 1.
400Participant characteristics at baseline
Table 1 provides the baseline characteristics of the 32 study
participants (height = 162 ± 5.4 cm; mass = 70.6 ± 10.3 kg;
BMI = 27.2 ± 4.4 kg∙m2). Eight (50%) participants in each group
had undergone chemotherapy. The baseline characteristics of
405participants in the intervention and usual care groups were
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similar in terms of age, mean time since diagnosis and end of
treatment, and other demographic and lifestyle factors (Table 1).
Exercise tolerance test and resting cardiovascular
outcomes
410 Baseline and post-intervention values for outcomes are provided
in Table 2. At baseline, mean relative _VO2max for all participants
tested was 25.3 ± 4.7 ml∙kg−1∙min−1. In accordance with age and
gender matched normative values, consistent with the American
College of Sports Medicine22, the median percentile of 20 ml∙kg-
415
−1∙min−1 corresponded to the “poor” category for cardiorespira-
tory fitness. Regarding criteria for maximal efforts, a plateau in
_VO2was achieved in all participants apart from one participant in
the usual care at baseline and one participants in the interven-
tion group post-intervention, an RER of ≥1.1 was achieved by all
420participants, and,�HR�peak within 10 b/min of the age-predicted
maximum was achieved in all apart from two participants at
baseline (1 each in intervention and usual care) and in partici-
pants three (1 in intervention, and 2 in usual care) post-interven-
tion. All participants met either the _VO2, RER, or HR��peak criteria
425at both baseline and post-intervention.
The magnitude-based inference (adjusted for baseline levels)
analysis revealed the effect of the PA intervention was likely to
have been beneficial (85% likelihood of a beneficial effect) on
relative _VO2max, compared with the usual care (see Table 3). In
430addition, given the Cohen’s d value, 67%of the intervention group
will be above the mean of the usual care group (i.e., Cohen’s U3
represents a 17% gain in the intervention group). The effect of the
intervention on absolute _VO2max was also likely beneficial (82%
likelihood of a beneficial effect, see Table 3). Given the Cohen’s d
435value, 66% of the intervention group will be above the mean of
Figure 1. Flow of participants through the study.
Figure 2. Path unstandardized coefficients and standard errors (SE) for simple mediation analysis of relationship between group allocation (X) and cardiorespiratory
fitness (Y) as mediated by body mass (M). Note: Dotted line denotes the effect of group allocation on cardiorespiratory fitness when body weight is not included as a
mediator (c = total effect).AQ19 �
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the usual care group (i.e., Cohen’s U3 represents a 16% gain in the
intervention group). The magnitude-inference approach revealed
no likely beneficial effects of the intervention on any of the
exercise tolerance or resting cardiovascular health outcomes,
440 and the 90% CI for each of the effect sizes contained zero.
Baseline and post-intervention treadmill test RER values were
similar in both groups (intervention, baseline: 1.37 ± 0.14, post:
1.37 ± 0.11; usual care, baseline: 1.34 ± 0.10, post: 1.36 ± 0.09).
Physical activity and anthropometric outcomes
445 Based on the magnitude-based inferences approach, for those
who completed the trial, the effect of the intervention was
likely beneficial on total PA and moderate PA (91% and 82%
likelihood of a beneficial effect, respectively) compared to
usual care. Based on the effect sizes, 76% of the total PA and
450 72% of the moderate PA values of the intervention group will
be above the mean of the usual care group (i.e., using Cohen’s
U3 Index, the percentile increase in the intervention group was
26% and 22%, respectively). The effect of the intervention on
vigorous PA levels was unclear. This lack of a clear effect likely
455reflects the fact that nine participants in the intervention
group and six in the usual care group reported no vigorous
PA at both baseline and post-intervention, one participant in
the intervention group and four in the usual care group
reduced vigorous PA, while five intervention group and four
460usual care participants increased their vigorous PA. No asso-
ciation was found between pre-post-intervention changes in
relative _VO2max and changes in self-reported moderate-to-
vigorous PA (r = .16, p = .45).
Mediation analysis of the effect of PA intervention on
465cardiorespiratory fitness through body mass
The total effect of group allocation on cardiorespiratory fitness
was significant, c = −2.09, t(27) = −2.09, p < .05; allocation to
usual care group predicted an approximate 2 ml∙kg−1∙min−1
decrease in cardiorespiratory fitness. Group allocation was not
470significantly predictive of the hypothesized mediating vari-
able, body mass; a = .939, t(27) = .627, p > .05. When control-
ling for group allocation, body mass was significantly
predictive of cardiorespiratory fitness, b = -.365, t
(26) = −3.34, p < .01. The estimated direct effect of group
475allocation on cardiorespiratory fitness, controlling for body
mass, was c′ = −1.75, t(26) = −2.04, p > .05. Figure� AQ10�2 shows
the unstandardized path coefficients for this mediation analy-
sis. Cardiorespiratory fitness was not well predicted from
group allocation and body mass, with adjusted R2 = .4 and F
480(2, 26) = 8.58, p < .01. However, the indirect effect of group
allocation on cardiorespiratory fitness through body mass was
not significant, ab = -.34, BCa bootstrapped 95% CI = −1.32 to
Table 1. Personal characteristics of the participants at baseline (intervention,







Mean±s age (years) 52.3 ± 9.6 52.5 ± 10.7 52.0 ± 8.6
Mean±s time since diagnosis
(week)
40.6 ± 24.5 41.3 ± 25.5 39.9 ± 25.4
Mean±s weeks since end of
treatment
10.9 ± 9.2 10.1 ± 9.4 11.6 ± 11.6
Ethnic Origin
White British 32 (100) 16 (100) 16 (100)
BMI (kg/m2)
Obese (BMI ≥ 30) 8 (25) 5 (31) 3 (19)
Overweight (BMI 25–29.9) 12 (38) 6 (38) 4 (25)
Normal (BMI 18–24.9) 12 (38) 5 (31) 7 (44)
Underweight (BMI < 18) 0 (0) 0 (0) 0 (0)
Family History of breast cancer
Yes 6 (19) 3 (19) 3 (19)
No 26 (81) 13 (81) 13 (81)
Smoking:
Ever 12 (38) 2 (13) 10 (50)
Never 20 (63) 14 (70) 6 (38)
Alcohol drinkers
Yes 25 (78) 11 (69) 14 (88)
No 7 (22) 5 (31) 2 (12)
Co-morbidities:
Diabetes 1 (3) 1 (6) 0 (0)
Hypertension 4 (13) 3 (18) 1 (6)
High Cholesterol 3 (9) 2 (13) 1 (6)
Heart disease 2 (6) 1 (6) 1 (6)
Vascular disease 1 (3) 0 (0) 1 (6)
Asthma or chronic bronchitis 4 (13) 1 (6) 3 (18)
Osteoarthritis 6 (19) 2 (13) 4 (25)
Rheumatoid arthritis 2 (6) 1 (6) 1 (6)
Kidney disease 2 (6) 0 (0) 2 (13)
Liver disease 1 (3) 0 (0) 1 (6)
Currently menstruating 7 (22) 3 (19) 4 (25)
Yes 25 (78) 13 (81) 12 (75)
No
Marital Status 27 (84) 15 (94) 12 (75)
Married/living with partner 5 (16) 1 (6) 4 (25)
Not married
Education 16.9 ± 2.0 16.6 ± 1.9 17.1 ± 2.2




17 (53) 9 (56) 8 (50)
Physical activity (IPAQ categories)
Low 9 (28) 4 (25) 5 (31)
Moderate 19 (59) 12 (75) 7 (44)
High 4 (13) 0 4 (25)
Key: OC = oral contraceptive.
Table 2. Baseline and post-intervention data for exercise tolerance test, body
mass and physical activity (PA, MET-min∙week) variables†.








1713 ± 318 1834 ± 296 1816 ± 264 1852 ± 223
_VO2max
(ml∙kg−1∙min−1)
24.1 ± 4.8 26.2 ± 5.3 26.6 ± 4.4 26.6 ± 3.3
Time to
Exhaustion (sec)
471 ± 105 531 ± 100 523 ± 76 545 ± 49
Peak Heart rate
(bpm)
176 ± 11 181 ± 9 174 ± 14 174 ± 16
Resting SBP
(mm∙Hg−1)
125 ± 10 126 ± 14 127 ± 13 126 ± 12
Resting DBP
(mm∙Hg−1)
78 ± 6 78 ± 8 82 ± 8 80 ± 6
Resting MAP
(mm∙Hg−1)
97 ± 10 98 ± 14 99 ± 11 96 ± 9
Mass (kg) 72.2 ± 12.0 71.0 ± 12.7 69.0 ± 8.3 70.1 ± 7.0
Total PA 604 (1058) 1388 (661) 1313 (2023) 1497 (1623)
Leisure PA 308 (569) 792 (572) 428 (930) 594 (896)
Walk PA 404 (637) 752 (726) 347 (404) 545 (743)
Moderate PA 202 (961) 586 (636) 599 (946) 819 (1651)
Vigorous PA 0 (0) 0 (320) 0 (270) 0 (180)
Descriptive statistics presented as either mean ± SD or median (interquartile
range) depending on distribution of data;
†Post-intervention data were only available for the 15 participants in the
intervention and the 14 participants in the usual care.
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.86. The ratio of indirect to total effect suggests that a rela-
tively small part of the effect of group allocation (i.e., alloca-
485 tion to PA or usual care) on cardiorespiratory fitness is
mediated by body mass, PM = .16.
Discussion
In our sample of breast cancer survivors, magnitude-based
inference analysis revealed “likely” at least small beneficial
490 effects on both relative and absolute cardiorespiratory fitness,
and total and moderate PA over the course of the intervention
period in the intervention group compared to the usual care
group. Furthermore, mediation analysis revealed that only a
small proportion of the observed increases in _VO2max in the
495 PA intervention group were mediated by changes in body
mass. No “likely” beneficial effects of the intervention were
found for any of the other exercise tolerance or resting cardi-
ovascular health outcomes.
The mean _VO2max values of the post-adjuvant therapy
500 breast cancer survivors in this current study are similar to
that reported in previous studies in which cardiorespiratory
fitness was measured directly (Burnett, Kluding, Porter, Fabian,
& Klemp, 2013; Courneya et al., 2003; Dolan et al., 2015;
Herrero et al., 2006; Hutnick et al., 2005; Irwin et al., 2014;
505 Jones et al., 2012; Mehnert et al., 2011; Peel et al., 2009). The
low _VO2max values reflect the poor physical condition of this
cohort of breast cancer survivors. Their cardiopulmonary fit-
ness levels were lower than the values associated with a three-
fold increase in risk of breast cancer mortality a previous study
510 (Peel et al., 2009). Therefore, the values reported in the current
study may indicate an increased risk of breast cancer mortality
in our sample and the need for this population to improve
cardiorespiratory fitness and overall health status.
We found increases in relative _VO2max values of 7.7% in
515 the PA intervention group, compared to no change (-.2%) in
the usual care group. This percentage change, represented a
change realtive _VO2max values of 1.87 ml/kg/min, which was
less than the 3.5 ml/kg/min (1 MET) change in cardiorespira-
tory fitness associated with significantly lower risk of breast
520cancer death (Peel et al., 2009). However, the magnitude of
this treatment effect was within the 6.5% to 17% increases
observed in previous studies assessing the effect of PA on
_VO2max in post-adjuvant therapy breast cancer survivors
(Courneya et al., 2003; Dolan et al., 2015; Herrero et al., 2006;
525Hutnick et al., 2005; Irwin et al., 2014; Mehnert et al., 2011).
Therefore, the improvements observed in cardiorespiratory
fitness in the current study are encouraging given the home-
based and moderate-intensity nature of the intervention.
Improvements in relative _VO2max can enhance the ability to
530perform activities of daily living, increase independence, pro-
mote a sense of well-being, and may ultimately confer a
positive survival benefit (Herrero et al., 2006; Peel et al., 2009).
The lack of change in relative _VO2max observed in the usual
care group of the current study, despite a slight improvement in
535absolute _VO2max, can almost entirely be attributed to a non-
significant increase in body mass (i.e., the increase in absolute
_VO2max was equivalent to the increase in body mass). However,
the increase in relative _VO2max observed in the intervention
group can only partially be explained by a reduction in body
540mass, given the improvements in absolute _VO2max (i.e., the
increase in relative _VO2max was higher than that expected for
the reduction in body mass observed). Therefore, mechanisms
other than reduced body mass may be responsible for the
improvements in relative _VO2max observed in the intervention
545group. The mechanisms by which PA can increase _VO2max in
breast cancer survivors remains to be elucidated. However, pre-
vious studies of postmenopausal women attributed PA-induced
increases in _VO2max to adaptations in skeletal muscles (Spina,
1999; Spina, Ogawa, Miller, Kohrt, & Ehsani, 1993). AQ11�Adaptations
550associated with prolonged aerobic exercise, such as a greater left
ventricular ejection fraction resulting from a more compliant
cardiac chamber, capillary density, myoglobin concentrations,
and muscle glycogen, facilitate improvements in cardiac output
Table 3. Magnitude-based inference analysis of changes in cardiorespiratory fitness ( _VO2 max) and additional exercise tolerance test variables, physical activity (PA),
and anthropometric measures in intervention and usual care groups and qualitative inferences about the intervention effects (all PA data reported as MET-min∙wk−1).
Change in Measure (%) from Baseline to Post-intervention
Variable
Intervention mean
(s as a CV)
Usual care mean
(s as a CV)




Qualitative inference (% likelihood
of at least a small effect)
_VO2max (ml∙min
−1) 5.8 (11.7) −0.8 (8.1) 6.7 (.5 to 13.3) .40 (.03 to .77) Likely beneficial (82%)
_VOmax (ml∙kg−1∙min−1) 7.7 (12.0) −0.2 (10.4) 7.9 (.8 to 15.4) .44 (.05 to .83) Likely beneficial (85%)
TTE (sec) 12.7 (20.0) 4.9 (11.2) 7.5 (−2.2 to 18.1) .37 (-.12 to .86) Possibly beneficial (72%)
HR peak (bpm) 2.2 (4.9) −0.2 (3.1) 2.4 (-.1 to 5.0) .32 (-.02 to .65) Possibly harmful (72%)
HR rest (bpm) −5.6 (9.5) −8.0 (12.3) 2.5 (−4.1 to 9.6) .20 (-.33 to .72) Unclear
SBP rest (mmHg) 1.1 (10.9) −1.4 (5.2) 2.5 (−2.7 to 7.9) .25 (-.28 to .77) Unclear
DBP rest (mmHg) 1.2 (8.7) −2.4 (6.9) 3.7 (−1.0 to 8.8) .39 (-.12 to .91) Possibly harmful (73%)
MAP rest (mmHg) .7 (12.4) −3.4 (7.5) 4.3 (−1.9 to 10.9) .35 (-.16 to .87) Possibly harmful (69%)
Total PA 79.8 (74.6) 4.6 (151.3) 71.9 (5.2 to 180.8) .73 (.07 to 1.40) Likely beneficial (91%)
Walking PA −11.9 (1141.5) 31.1 (994.6) −32.8 (−85.8 to 218.3) −.22 (−1.08 to .64) Unclear
Moderate PA 116.1 (505.9) −29.4 (938.2) 206.0 (−19.3 to 1061.2) .59 (-.11 to 1.28) Likely beneficial (82%)
Vigorous PA 399.2 (3067.3) −11.2 (8853.4) 462.1 (−56.2 to 7171.5) .64 (-.31 to 1.59) Unclear
Mass (kg) −2.1 (6.4) −.7 (3.5) −1.4 (−4.5 to 1.7) −.10 (-.32 to .12) Likely trivial (76%)
BMI (kg/m2) −2.2 (6.1) −1.0 (3.6) −1.2 (−4.2 to 1.9) −.08 (-.28 to .12) Likely trivial (83%)
Key: CV, coefficient of variation; s indicates standard deviation; 95% CI, 95% confidence interval; ES, effect size (Cohen’s d; effect estimate/pooled baseline s); _VO2
max, maximal oxygen uptake; TTE, time to exhaustion; HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure; BMI,
body mass index.
Analysis based on 29 participants (intervention = 15; usual care = 14).
Beneficial effect reflects an increase in _VO2 max, TTE, and PA measures and a decrease in anthropometric and cardiovascular measures.
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and arterial-venous oxygen difference, which can in turn
555 improve _VO2max (Bassett & Howley, 2000; Holloszy & Coyle,
1984; Levine, 2008). Thus, it is plausible that both increases in
cardiac output and arterial-venous oxygen difference contribu-
ted to the albeit small physiologic adaptations observed in this
current trial. However, we found no association between pre-
560 post-intervention changes in relative _VO2max and changes in
self-reportedmoderate-to-vigorous PA. We suggest that this lack
of association may be attributed to the limitations of self-
reported PA, such as misclassification, recall and social desirabil-
ity biases (Shephard & Vuillemin, 2003). In support of this sugges-
565 tion, cardiorespiratory fitness is mainly, but not completely (due
to genetic contributions), determined by recent PA patterns and
is considered to be an objective measure of PA patterns that is
superior to self-report (Blair, Cheng, & Holder, 2001). Therefore,
the assessment of self-reported previous 7-day PA may not have
570 been sensitive enough to detect the changes in PA patterns
required to induce the observed changes in _VO2max.
Furthermore, cardiorespiratory fitness may be a stronger predic-
tor of health outcomes, including cancer mortality, than self-
reported PA (Blair et al., 2001). Nevertheless, we cannot discount
575 the possibility that psychological factors, such as increased moti-
vation, self-confidence and tolerance, influenced the pre-post
intervention changes in _VO2max.
The limitations of our trial merit comment. Our small sample
had an average age younger than is typical for women with a
580 breast cancer. The highest proportion of women diagnosed with
breast cancer rates are aged 60 to 69 years (Cancer Research UK,
2006).AQ12 �Due to the non-blinding of the outcome assessor to the
allocation of participants, we cannot rule out the possibility that
performance bias influenced our results. Performance bias can be
585 introduced if the outcome assessor consciously or unconsciously
provided more encouragement during exercise tolerance tests to
the participants in the intervention group than those in the usual
care group, whichmay have resulted inmore favourable scores in
the intervention group. Although, indirect calorimetry is the gold
590 standardmethod of assessing _VO2max, breath-by-breath systems
can have a typical measurement error of approximately ±2–3%,
and therefore, may account for a portion of the ~8% improve-
ment in _VO2 max observed in the intervention group (Robergs &
Burnett, 2003). However, every attempt was made to standardise
595 protocols across groups and the outcome assessor was carefully
trained and monitored for objective and consistent administra-
tion of exercise test protocols. While attempts were made to
reduce performance bias attributed to the outcome assessor,
the blinding of participants to group allocation was not possible.
600 This inability to blind participants is an inherent limitation of PA
studies, which may bias participant responses and behaviours
because of their awareness of the study purpose and desire to
please the research staff.
In the context of the limitations outlined above, we found
605 likely beneficial increases in relative and absolute cardiorespira-
tory fitness, and total andmoderate PA in the intervention group
compared to the usual care group. Our data highlight the poten-
tial effectiveness of a home-based PA intervention coupled with
face-to-face counselling and telephone support in providing
610 beneficial effects on cardiorespiratory fitness, which may influ-
ence breast cancer outcomes and CVD risk. Large sample
prospective longitudinal randomised controlled trials are needed
to determine the impact of improvements in cardiorespiratory
fitness on breast cancer outcomes and development of CVD in
615breast cancer survivors.
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